Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer
Abstract Over the past two decades, immune cell therapy has emerged as a potent treatment for multiple cancers, first through groundbreaking leukemia therapy, and more recently, by tackling solid tumors. Developing successful therapeutic strategies using live cells could benefit from the ability to...
Main Authors: | Fanny Chapelin, Christian M Capitini, Eric T Ahrens |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2018-10-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-018-0416-9 |
Similar Items
-
Cell Labeling for 19F MRI: New and Improved Approach to Perfluorocarbon Nanoemulsion Design
by: Jonathan Williams, et al.
Published: (2013-09-01) -
Design, Characterization and Molecular Modeling of New Fluorinated Paramagnetic Contrast Agents for Dual <sup>1</sup>H/<sup>19</sup>F MRI
by: Emilie Hequet, et al.
Published: (2020-02-01) -
Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions
by: Anne H. Schmieder, et al.
Published: (2015-12-01) -
Functionalized Gold Nanoparticles as Contrast Agents for Proton and Dual Proton/Fluorine MRI
by: Maria Şologan, et al.
Published: (2019-06-01) -
Fluorinated PLGA-PEG-Mannose Nanoparticles for Tumor-Associated Macrophage Detection by Optical Imaging and MRI
by: Giorgia Zambito, et al.
Published: (2021-08-01)